Figure 1. Model for T cell response in COVID-19 relative to patient risk.
Patients at risk for severe COVID-19 disease (advanced age and higher comorbidity) show higher T cell responses than those at low risk. However, the activated T cells from patients at risk have impaired IFN-γ and enhanced IL-2 production.